Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1228PDF: 976HTML: 209 -
-
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1610PDF: 1089HTML: 114 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2928PDF: 887HTML: 1745 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3225PDF: 1330HTML: 4129 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2779PDF: 1112HTML: 11215 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2683PDF: 1000HTML: 2265 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1449PDF: 757Suppl. Files: 320Html: 133 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1326PDF: 821HTML: 127 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
467PDF: 241HTML: 77 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1400PDF: 896Suppl. Files: 452HTML: 233 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1028PDF: 1150Suppl. Files: 569HTML: 82 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2232PDF: 865HTML: 2092 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1652PDF: 644HTML: 2429 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9033PDF: 6047HTML: 87944Fig.1b: 183Fig.1c: 186Fig.2a: 175Fig.2b: 174Fig.4: 186Fig.2c: 181Fig.3: 179Tab.1: 225Tab.2: 205Tab.3: 188Tab.4: 220Fig1a: 180 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1671PDF: 1435HTML: 241 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2787PDF: 1003HTML: 5518 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1704PDF: 831HTML: 142 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
944PDF: 1204HTML: 106 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
966PDF: 611HTML: 222 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3523PDF: 1558HTML: 78 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1555PDF: 599HTML: 187 -
How I treat acute and persistent sickle cell pain
1910PDF: 1112HTML: 482 -
-
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1821HTML: 1434PDF: 1078 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2228PDF: 875HTML: 1999Fig 1 Rossi: 173







